The
global Cell Culture Market size is
expected to reach USD 60.27 billion by 2030, expanding at a CAGR of 11.9% from
2022 to 2030, according to a new report by Grand View Research, Inc. This can
be attributed to the increase in biopharmaceutical production, advancements in
vaccine research and development, and increasing focus on genetic engineering
applications that rely heavily on cell culture techniques.
Innovations
in cell culture workflow automation, such as the commercial development of
integrated robotic liquid handling systems, are expected to significantly boost
the capabilities of current cell culture technologies. For instance, culturing
processes are expected to witness improvements in capacity handling and
efficiency, and reproducibility in operations. Similarly, automation in cell
line development technologies is gaining traction with the launch of new
platforms. For instance, in October 2021, CYTENA launched C.STATION, a fully
automated cell line development platform, for enhancing antibody and gene
therapy production. Such product launches are likely to increase the market
penetration of cell culture offerings.
Cell
culture models play a pivotal role in the development of novel therapeutics for
diseases such as diabetes, cancer, and Parkinson’s diseases. With the
increasing emphasis on research and development activities exploring
therapeutic candidates for such diseases, the demand for customized media for use
in preclinical research is expected to drive the market. Furthermore, demand
for serum-free media is likely to witness significant growth due to increasing
quality constraints in biopharmaceuticals and the requirement for highly
consistent and standardized culturing conditions.
The
COVID-19 pandemic has boosted the demand for cell culture products due to the
significant role played by culturing technologies in the discovery of novel
diagnostic and therapeutic options for the disease. For instance, research
applications such as high-throughput COVID-19 drug screening for the
identification of potential drug candidates or investigations aimed at
understanding the mechanism of viral entry into the host cells are expected to
positively affect the market growth. Furthermore, culturing techniques offer
essential tools for the production of viral particles for vaccine development,
thereby broadening the growth prospects in this domain.
Related Press
Release@ Cell Culture Market Report
Cell Culture Market Report Highlights
- By
consumable, the media segment accounted for the largest revenue share of
over 50.0% in 2021 due to the availability of a variety of serum- and
animal component-free and customized media alternatives, which has
increased the market penetration for media products
- Based on
product, culture systems held the largest revenue share of over 25.0% in
2021. This can be attributed to the technological advancements in
automated systems for research & development applications
- The
biopharmaceuticals application segment dominated the market in 2021 with a
revenue share of over 25.0% due to the involvement of mammalian lines,
such as the Chinese hamster ovary, in the manufacturing of
biopharmaceuticals and the rising demand for non-conventional drugs
- North
America held the largest revenue share in 2021 due to high research and
development investments, the presence of a well-established scientific
infrastructure, significant demand for animal component-free media, and
other factors
- The Asia
Pacific region is estimated to grow at the fastest rate over the forecast
period due to the growing healthcare expenditure, rising awareness
regarding regenerative therapies, and a large potential for clinical
research applications
List of Key Players of the Cell Culture Market
- Bio-Rad
Laboratories, Inc.
- Thermo
Fisher Scientific, Inc.
- Becton,
Dickinson and Company
- Merck KGaA
- Sartorius AG
- VWR
International, LLC
- Eppendorf SE
- PromoCell
GmbH
- Bio-Techne
Corporation
- BioSpherix,
Ltd.
Related Reports
3D
Cell Culture Market
Cell Culture Market Segmentation
Grand
View Research has segmented the global cell culture market based on consumable,
product, application, and region:
Cell Culture Consumable Outlook (Revenue, USD
Million, 2018 - 2030)
- Media
- Minimum
Essential Media (MEM)
- RPMI 1640
Media
- DMEM/F-12
Media
- F-10 Serum
Free Media
- BME Media
- Insect
Media
- Other Media
- Sera
- Fetal
Bovine Serum
- Other
AnimalSerum
- Reagents
- Albumin
- Other
Cell Culture Product Outlook (Revenue, USD Million, 2018
- 2030)
- Culture
Systems
- Incubators
- Centrifuges
- Cryostorage
Equipment
- Biosafety
Equipment
- Pipetting
Instruments
Cell Culture Application Outlook (Revenue, USD
Million, 2018 - 2030)
- Biopharmaceuticals
- Tissue
Culture & Engineering
- Vaccine
Production
- Drug
Development
- Gene Therapy
- Toxicity
Testing
- Cancer
Research
- Others
Cell Culture Regional Outlook (Revenue, USD Million,
2018 - 2030)
- North
America
- U.S.
- Canada
- Europe
- U.K.
- Germany
- France
- Italy
- Spain
- Asia Pacific
- Japan
- China
- India
- Australia
- South Korea
- Latin
America
- Brazil
- Mexico
- Middle East
and Africa (MEA)
- South
Africa
- Saudi
Arabia
- UAE
About Us:
Grand
View Research, Inc. is a U.S. based market research and consulting company,
registered in the State of California and headquartered in San Francisco. The
company provides syndicated research reports, customized research reports, and
consulting services. To help clients make informed business decisions, the
company offers market intelligence studies ensuring relevant and fact-based
research across a range of industries including technology, chemicals,
materials, healthcare and energy.
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-95196
Email: sales@grandviewresearch.com
For More Information: https://www.grandviewresearch.com
No comments:
Post a Comment